immunity News and Research

RSS

University of Leicester study provides new insights into preventer and reliever treatments for asthma

A new study at the University of Leicester is probing why asthma relief inhalers might actually make asthma worse- and what can be done about it.

13 Jan 2010

moksha8 receives approval to import and use peramivir in patients with H1N1 influenza A in Mexico

moksha8 and BioCryst today announced that moksha8 has been granted approval from COFEPRIS (The Federal Commission for the Protection against Sanitary Risk) in Mexico for the importation and use of peramivir in patients with influenza associated with the 2009 H1N1 influenza A strain.

13 Jan 2010

Research reveals how cancers shield themselves from immune attack

Melanoma, if not detected in its early stages, transforms into a highly deadly, treatment-resistant cancer. Although the immune system initially responds to melanoma and mounts anti-tumor attacks, these assaults are generally ineffective, allowing more advanced melanomas to win the battle and spread beyond the primary site.

13 Jan 2010

NOVAVAX completes pre-clinical safety and efficacy study of its RSV vaccine candidate

Novavax, Inc. announced today that it has successfully completed a pre-clinical safety and efficacy study of its RSV vaccine candidate in cotton rats. Results from this study are needed to support an Investigational New Drug (IND) application to advance this novel recombinant F protein particle based RSV (RSV-F) vaccine candidate into clinical development. This vaccine candidate is composed of recombinant 'F' or 'fusion' protein of RSV which is used by the virus to infect and fuse with cells in the respiratory tract and cause disease.

13 Jan 2010

Phase I clinical trial of XRX-001 for yellow fever initiated

Xcellerex, Inc. today announced that it has initiated a Phase I clinical trial of XRX-001, a novel, prophylactic vaccine against yellow fever, a tropical virus disease that is often fatal.

12 Jan 2010

H1N1 flu vaccines and other resources for remaining healthy to be offered at Pennsylvania Farm Show

The Department of Health is offering free H1N1 flu vaccines and other resources for remaining healthy at its exhibit at the Pennsylvania Farm Show, which runs through Jan. 16.

12 Jan 2010

Official H1N1-related death count approaches 13,000 worldwide, WHO says

H1N1 (swine flu) has killed 12,799 people worldwide since the virus first emerged, the WHO said on Friday, United Press International reports (1/8). According to the WHO, more than half of the H1N1-related deaths worldwide occurred in the Americas, China Daily reports (1/9).

12 Jan 2010

Frequent chlamydia screening does not reduce infection in teenage girls

Frequent testing and treatment of infection does not reduce the prevalence of chlamydia in urban teenage girls, according to a long term study by Indiana University School of Medicine researchers published in the January 1, 2010 issue of the Journal of Infectious Diseases.

8 Jan 2010

Rituximab treatment reduces patients' response to pneumonia vaccine

Researchers from Johns Hopkins University determined that immune responses to the tetanus vaccine were not changed when rituximab in combination with methotrexate (MTX) was compared with MTX alone in patients with rheumatoid arthritis (RA).

7 Jan 2010

Sunlighten to unveil mPulse Series in April 2010

Sunlighten(TM) (www.sunlighten.com) is proud to unveil its mPulse(TM) Series, set to launch in April 2010, which is the world's first sauna with personalized biofeedback tracking as well as customizable full spectrum infrared heat that targets specific health concerns.

4 Jan 2010

Cepheid granted EUA for Xpert Flu A Panel test

Cepheid today announced it has been granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Xpert® Flu A Panel test.

4 Jan 2010

Cardiologist wins stimulus grant to identify biomarkers of idiopathic pulmonary hypertension

Johns Hopkins Children's Center cardiologist Allen Everett recently won more than $460,000 in stimulus grant funding to identify the biomarkers of idiopathic pulmonary hypertension (IPH), a progressive and highly lethal condition in children and adults marked by persistently elevated pressure in the artery that carries blood from the heart to the lungs.

31 Dec 2009

Presence of Streptococcus pneumoniae could predict risk of severe disease in H1N1 pandemic influenza

The presence of the Streptococcus pneumoniae in samples that can be easily obtained in clinics and emergency rooms may predict risk of severe disease in H1N1 pandemic influenza.

31 Dec 2009

Promising results from Soligenix' RiVax vaccine against ricin toxin

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today the publication of an article in the January 2010 edition of Infection and Immunity, detailing the characteristics of several immunodominant regions of ricin A chain, the antigenic component of RiVax((TM)). RiVax((TM)) is Soligenix's vaccine to protect against exposure to ricin toxin and is currently being evaluated in Phase 1 human safety and immunogenicity trials, as well as nonhuman primate trials for efficacy.

29 Dec 2009

Majority of Australians think H1N1 vaccination is not necessary

Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.

23 Dec 2009

Food Safety News releases 2009 “Naughty” list, “Nice” list to follow

Food Safety News, the web-based newspaper that covers all things food safety, has published the first half of its 2009 Food Safety Naughty and Nice list. The website, which has had more than 75,000 unique visitors since its September, 2009 launch, compiled the list from stories it covered as well as input from the food safety community. The release of the finger-wagging “Naughty” list will be followed by a kudos-to “Nice” list, just in time for Santa’s sleigh.

23 Dec 2009

Scientists explain how smallpox viruses disrupt immune systems

A team of researchers working in a high containment laboratory at the Centers for Disease Control and Prevention in Atlanta, GA, have solved a fundamental mystery about smallpox that has puzzled scientists long after the natural disease was eradicated by vaccination.: they know how it kills us.

23 Dec 2009

Macomb County Health Department announces 2009 H1N1 influenza vaccination program

The last large H1N1 influenza vaccination clinic for the 2009 flu season has been scheduled by the Macomb County Health Department. It is free of charge and will take place next Monday, Dec. 28, at Bethesda Christian Church in Sterling Heights from 10 a.m. to 3 p.m. Everyone over 6 months of age can receive the vaccine at this clinic.

23 Dec 2009

New findings reveal POPG lipid can prevent RSV infection in lungs

Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.

22 Dec 2009

Malaria nasal vaccine, antimicrobial peptide against MRSA, and safer method to prolong orange juice shelf life

An experiemental nasally administered malaria vaccine prevented parasite transmission from infected mice to mosquitoes and could play an important role in the fight against human malaria. The researchers from Japan report their findings in the December 2009 issue of the journal Infection and Immunity.

19 Dec 2009

immunity News and Research

University of Leicester study provides new insights into preventer and reliever treatments for asthma

moksha8 receives approval to import and use peramivir in patients with H1N1 influenza A in Mexico

Research reveals how cancers shield themselves from immune attack

NOVAVAX completes pre-clinical safety and efficacy study of its RSV vaccine candidate

Phase I clinical trial of XRX-001 for yellow fever initiated

H1N1 flu vaccines and other resources for remaining healthy to be offered at Pennsylvania Farm Show

Official H1N1-related death count approaches 13,000 worldwide, WHO says

Frequent chlamydia screening does not reduce infection in teenage girls

Rituximab treatment reduces patients' response to pneumonia vaccine

Sunlighten to unveil mPulse Series in April 2010

Cepheid granted EUA for Xpert Flu A Panel test

Cardiologist wins stimulus grant to identify biomarkers of idiopathic pulmonary hypertension

Presence of Streptococcus pneumoniae could predict risk of severe disease in H1N1 pandemic influenza

Promising results from Soligenix' RiVax vaccine against ricin toxin

Majority of Australians think H1N1 vaccination is not necessary

Food Safety News releases 2009 “Naughty” list, “Nice” list to follow

Scientists explain how smallpox viruses disrupt immune systems

Macomb County Health Department announces 2009 H1N1 influenza vaccination program

New findings reveal POPG lipid can prevent RSV infection in lungs

Malaria nasal vaccine, antimicrobial peptide against MRSA, and safer method to prolong orange juice shelf life

Industry Focus eBook - Cell biology (5th edition) eBook

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Latest News